CD274 and neoplasm: These results revealed that YY2 overexpression/anti‐PD‐L1 combinatorial therapy induces chromosome missegregation, pyroptosis, and the development of the immune microenvironment in tumor lesions, triggering CTL proliferation and activation while preventing their exhaustion.